The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

Apoc1  -  apolipoprotein C-I

Mus musculus

Synonyms: Apo-CIB, ApoC-IB, Apoc1b, Apolipoprotein C-I, Apolipoprotein C1, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Apoc1

  • It has recently been shown that septic HDL is almost depleted from apolipoprotein CI (apoCI), suggesting that apoCI may be a protective factor in sepsis [1].
 

High impact information on Apoc1

 

Chemical compound and disease context of Apoc1

 

Biological context of Apoc1

  • We assessed whether physiological endogenous apoC-I levels are sufficient to modulate plasma lipid levels independently of effects of apoE on lipid metabolism by comparing apolipoprotein E gene-deficient/apolipoprotein C-I gene-deficient (apoe-/-apoc1-/-), apoe-/-apoc1+/-, and apoe-/-apoc1+/+ mice [5].
 

Anatomical context of Apoc1

  • OBJECTIVES: Recently, we reported that exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease is associated with enrichment of remnant lipoproteins with apolipoprotein C-I (apoC-I) [6].
 

Associations of Apoc1 with chemical compounds

  • We have isolated and characterized cDNA and genomic clones containing the mouse apolipoprotein C1 (Apoc1) gene [4].
 

Other interactions of Apoc1

  • First, we tested whether this distinction is due to additional mutation of the Apoc1 and/or Apoc2 genes in KOR-Apoe(shl) [7].

References

  1. Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsis. Berb??e, J.F., van der Hoogt, C.C., Kleemann, R., Schippers, E.F., Kitchens, R.L., van Dissel, J.T., Bakker-Woudenberg, I.A., Havekes, L.M., Rensen, P.C. FASEB J. (2006) [Pubmed]
  2. Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl. Shachter, N.S., Ebara, T., Ramakrishnan, R., Steiner, G., Breslow, J.L., Ginsberg, H.N., Smith, J.D. J. Clin. Invest. (1996) [Pubmed]
  3. Hepatic lipid accumulation in apolipoprotein C-I-deficient mice is potentiated by cholesteryl ester transfer protein. Gautier, T., Tietge, U.J., Boverhof, R., Perton, F.G., Le Guern, N., Masson, D., Rensen, P.C., Havekes, L.M., Lagrost, L., Kuipers, F. J. Lipid Res. (2007) [Pubmed]
  4. The mouse apolipoprotein C1 gene: structure and expression. Hoffer, M.J., van Eck, M.M., Havekes, L.M., Hofker, M.H., Frants, R.R. Genomics (1993) [Pubmed]
  5. Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL. Westerterp, M., de Haan, W., Berbée, J.F., Havekes, L.M., Rensen, P.C. J. Lipid Res. (2006) [Pubmed]
  6. Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis. Björkegren, J., Silveira, A., Boquist, S., Tang, R., Karpe, F., Bond, M.G., de Faire, U., Hamsten, A. Arterioscler. Thromb. Vasc. Biol. (2002) [Pubmed]
  7. Four strains of spontaneously hyperlipidemic (SHL) mice: phenotypic distinctions determined by genetic backgrounds. Matsushima, Y., Sakurai, T., Ohoka, A., Ohnuki, T., Tada, N., Asoh, Y., Tachibana, M. J. Atheroscler. Thromb. (2001) [Pubmed]
 
WikiGenes - Universities